[
  {
    "ts": "2026-02-25T10:14:02+00:00",
    "headline": "How The Evolving Wall Street Narrative Is Reframing Abbott Laboratories (ABT) Valuation Prospects",
    "summary": "Abbott Laboratories is back in focus after several research houses reset their price targets, with some cuts in the US$5 to US$29 range and at least one target lifted into the mid US$150s. Those moves reflect a split narrative, where some analysts point to execution risk and slower earnings translation. Others highlight Abbott’s broad healthcare portfolio and an upgrade that leans on its longer term positioning. As you read on, you will see how these shifting price targets feed into an...",
    "url": "https://finance.yahoo.com/news/evolving-wall-street-narrative-reframing-101402011.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bbc35121-0780-3838-9666-f2966346313c",
      "content": {
        "id": "bbc35121-0780-3838-9666-f2966346313c",
        "contentType": "STORY",
        "title": "How The Evolving Wall Street Narrative Is Reframing Abbott Laboratories (ABT) Valuation Prospects",
        "description": "",
        "summary": "Abbott Laboratories is back in focus after several research houses reset their price targets, with some cuts in the US$5 to US$29 range and at least one target lifted into the mid US$150s. Those moves reflect a split narrative, where some analysts point to execution risk and slower earnings translation. Others highlight Abbott’s broad healthcare portfolio and an upgrade that leans on its longer term positioning. As you read on, you will see how these shifting price targets feed into an...",
        "pubDate": "2026-02-25T10:14:02Z",
        "displayTime": "2026-02-25T10:14:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evolving-wall-street-narrative-reframing-101402011.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evolving-wall-street-narrative-reframing-101402011.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]